Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,

Slides:



Advertisements
Similar presentations
Photodynamic Laser Therapy for Lesions in the Airway
Advertisements

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,
Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,
Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting  Zoltán.
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 
Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction  Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.
Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
Outcomes of Reintervention on the Autograft After Ross Procedure
Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations  W. Brent Keeling, MD, Jose Binongo, PhD, Eric.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
Spinal Cord Stimulation for Patients With Refractory Angina and Previous Coronary Surgery  Elisabetta Lapenna, MD, Dino Rapati, MD, Paola Cardano, MS,
Impact of Preoperative Renal Dysfunction on Long-Term Survival for Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, W. Brent Keeling,
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
Does Diabetes Affect the Postoperative Outcomes After Total Arterial Off-Pump Coronary Bypass Surgery in Multivessel Disease?  Jae-Sung Choi, MD, PhD,
The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement  Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,
Incidence of Postoperative Stroke Using the Heartstring Device in 1,380 Coronary Artery Bypass Graft Patients With Mild to Severe Atherosclerosis of the.
Operative Results and Outcomes in Children With Shone's Anomaly
Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients  Faraz Kerendi, MD, John D. Puskas,
Transcatheter Aortic Valve Replacement Has Improved Short-Term but Similar Midterm Outcomes in Isolated Aortic Valve Replacement After Prior Coronary.
Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients  David C. Chang, PhD,
Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D
Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases  Haifeng Wang, MM, Hongsheng Lin, MM, Gening.
Fate of Functional Mitral Regurgitation and Predictors of Persistent Mitral Regurgitation After Isolated Aortic Valve Replacement  Hyun-Chel Joo, MD,
Surgical Resection of a Giant Coronary Aneurysm
Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation  Steven A. Farmer, MD, PhD, Kathleen L. Grady,
Intraoperative Radiofrequency Ablation for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery  Michael E. Halkos, MD, Joseph M. Craver,
Performing Coronary Artery Bypass Grafting Off-Pump May Compromise Long-Term Survival in a Veteran Population  Faisal G. Bakaeen, MD, Danny Chu, MD, Rosemary.
Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients  Giovanni Filardo, PhD, MPH,
Radial Artery Grafts in Women: Utilization and Results
Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery  James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,
Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass for the Treatment of Left Main Coronary Stenosis  Michael E. Halkos, MD, S. Tanveer.
Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma
Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence  Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,
Bartosz Rylski, MD, Nimesh D. Desai, MD, PhD, Joseph E
Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J
Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy  Jun Liu, MD, Zixiong Liu, MD, Qiang Zhao, MD, Anqing Chen, MD, Zhe.
Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D
A. Laurie W. Shroyer, PhD, MSHA, Jacquelyn A. Quin, MD, MPH, Todd H
Influence of Diabetes Mellitus on Long-Term Survival in Systematic Off-Pump Coronary Artery Bypass Surgery  Bertrand Marcheix, MD, Frédéric Vanden Eynden,
Clinical outcomes, angiographic patency, and resource utilization in 200 consecutive off- pump coronary bypass patients  John D Puskas, MD, Vinod H Thourani,
Statin in Combination With β-Blocker Therapy Reduces Postoperative Stroke After Coronary Artery Bypass Graft Surgery  Denis Bouchard, MD, Michel Carrier,
W. Brent Keeling, MD, Jose Binongo, PhD, Michael E
A. Thomas Pezzella, MD, Sari D
Off-Pump Coronary Artery Bypass Disproportionately Benefits High-Risk Patients  John D. Puskas, MD, Vinod H. Thourani, MD, Patrick Kilgo, MS, William Cooper,
Impact of Functional Status on Survival After Coronary Artery Bypass Grafting in a Veteran Population  Roberto Cervera, MD, Faisal G. Bakaeen, MD, Lorraine.
Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction  Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),
Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population  Christian McNeely, MD, Stephen.
Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?
Left-Sided Reoperations After Arterial Switch Operation: A European Multicenter Study  Vladimiro L. Vida, MD, PhD, Lorenza Zanotto, MD, Lucia Zanotto,
Vinod H. Thourani, MD, W. Brent Keeling, MD, Robert A
Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.
Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D
Off-Pump and On-Pump Coronary Artery Bypass Grafting Are Associated With Similar Graft Patency, Myocardial Ischemia, and Freedom From Reintervention:
Reoperation for Coronary Artery Bypass Grafting Surgery: Outcomes and Considerations for Expanding Interventional Procedures  Simon Maltais, MD, PhD,
Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients  Staffan Bjessmo, MD,
Influence of concomitant CABG and urgent/emergent status on mitral valve replacement surgery  Vinod H Thourani, MD, William S Weintraub, MD, Joseph M.
Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS 
Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery  Chuntao Wu, MD, PhD, Edward L. Hannan,
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy  Tomas Gudbjartsson,
Influence of On-Pump Versus Off-Pump Techniques and Completeness of Revascularization on Long-Term Survival After Coronary Artery Bypass  Omar M. Lattouf,
Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms  Robert E. Merritt, MD, Douglas J. Mathisen,
Kim I. de la Cruz, MD, Faisal G
Presentation transcript:

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD, Omar M. Lattouf, MD, PhD, John D. Puskas, MD, Patrick Kilgo, MS, William A. Cooper, MD, Cullen D. Morris, MD, Robert A. Guyton, MD, Vinod H. Thourani, MD  The Annals of Thoracic Surgery  Volume 86, Issue 5, Pages 1431-1437 (November 2008) DOI: 10.1016/j.athoracsur.2008.06.078 Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier 5-year overall survival by hemoglobin A1c (HbA1c) stratification: 7.0% or greater (light line) versus less than 7.0% (heavy line). At 5 years, 87.6% of patients with HbA1c less than 7.0% survived, compared with 82.3% of patients with HbA1c of 7.0% or greater (p = 0.001). The Annals of Thoracic Surgery 2008 86, 1431-1437DOI: (10.1016/j.athoracsur.2008.06.078) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier 5-year overall survival by diabetes mellitus status. At 5 years, 89.8% of patients without diabetes (light line) survived, compared with 81.1% of patients with diabetes (heavy line; p < 0.001). The Annals of Thoracic Surgery 2008 86, 1431-1437DOI: (10.1016/j.athoracsur.2008.06.078) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Kaplan-Meier 5-year overall survival among patients with diagnosis of diabetes mellitus according to hemoglobin A1c (HbA1c) less than 7.0% (heavy line) versus 7.0% or greater (light line). Among diabetic patients, there was no significant difference in 5-year survival according to HbA1c less than 7.0% versus 7.0% or greater (p = 0.37). The Annals of Thoracic Surgery 2008 86, 1431-1437DOI: (10.1016/j.athoracsur.2008.06.078) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Kaplan-Meier 5-year overall survival among patients with diagnosis of diabetes mellitus according to treatment method: insulin therapy (light line) versus no insulin therapy (heavy line). At 5 years, 78.3% of diabetic patients treated with insulin survived, compared with 82.4% of diabetic patients treated without insulin (p = 0.006). The Annals of Thoracic Surgery 2008 86, 1431-1437DOI: (10.1016/j.athoracsur.2008.06.078) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions